Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin for cGVHD Prevention in HPCT
NCT01217723Phase 3Unknown
- Sponsor
- McMaster University
- Start
- Apr 2010
- Primary completion
- Jan 2014
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin in chronic graft-versus-host disease (cGVHD), sponsored by McMaster University. Status: unknown.
02
Drugs
antithymocyte globulin
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01217723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217723.